Vor Biopharma Inc. amended its 2021 Equity Incentive Plan, increasing shares by 25 million and decreasing annual automatic additions from 5% to 4% of total shares; approved by stockholders on August 25, 2025. They also plan a reverse stock split between 1-for-5 and 1-for-30, and registered up to $119.7 million in stock sales.